Recently the project of polypeptide drugs export base (under construction) founded by Shenzhen Hybio Engineering Co. LTD was regarded as State High-tech Industrialization Model Project by National Development and Reform Commission.
In the whole world, the majority of polypeptide materials makers are centralized in Europe and the production of polypeptide drugs is monopolised by big multinational enterprises. Now no Indian or Chinese enterprise have passed DMF or COS authentication for polypeptide materials or preparations.
After finished the project, Shenzhen Hybio Engineering should be the first Chinese enterprise to export polypeptide products.